The pharmaceuticals industry, which has made life-saving drugs available at lower costs, is facing troubles in opening letters of credit (LCs) to import much-needed raw materials and capital machinery owing to the US dollar crunch.
The pharmaceuticals sector in Bangladesh displayed the fastest growth in profit between 2015 and 2020 as more people, armed with rising purchasing power, afford more healthcare products.
Anti-ulcer drugs are the top-selling medicines in Bangladesh with sales clocking more than 12 per cent growth annually since 2015 driven by unhealthy food habits, use of excess oil and spices in food preparation and food adulteration.